Formulation solutions and biologics development
Faster development, paving the way to clinical trials
The ability to efficiently move biologics through the pre-clinical process gives patients the best chance of becoming lifesaving medicines to reach patients faster. That’s the aim with our formulation products and services—running the gamut from formulation development to manufacturing.
Soluble Biotech is now Predictive Oncology
Formulation services
We help identify high-solubility and high-stability formulations thanks to our proprietary HSC technology.
Biologics development
Our technologies and services help expedite and streamline development—from analytical development to endotoxin removal.
Biologics manufacturing
We offer GMP and non-GMP manufacturing services—including endotoxin removal and ICH stability studies.
Proprietary technology cuts time and resources
Our automated High Throughput Self-Interaction Chromatography (HSC™) Technology Platform decreases time and manpower required to optimize formulations.
What can formulation solutions
do for you?
Identifying soluble and stable formulations for a candidate biologic drug molecule can take a long time. Our soluions compress the timeline to less than 6 months. It is all thanks to our proprietary HSC instrument that quickly and accurately measure protein-protein interactions.
After a formulation is identified, the FDA requires long-term stability testing and thorough endotoxin removal to progress candidate drugs to human clinical trials. We provide a full range of long-term stability tests to help pharmaceutical companies progress their biologic candidates to clinical trials. Our endotoxin removal products and services provide a superior method—thanks to multiple molecular interactions, plus endotoxin removal media that allows for better recovery of the biologic molecule than that of competitors.
Talk to us about formulation solutions today.
Complete the form and we’ll be in touch to discuss customized solutions for your needs.
![pamela_contact1 pamela_contact1](https://predictive-oncology.com/wp-content/uploads/2023/02/pamela_contact1.png)
News & resources
White paper validates highly reproducible drug response data. Results enable AI platform to model and predict patient outcomes on historical samples Leveraging more than 20...
A recent white paper released by Predictive Oncology’s highlights the challenge of late-stage clinical trial failures and the company’s ability to better navigate those obstacles...
Company expands AI/ML driven capabilities to pursue novel biomarker discovery to predict patient outcomes and drug response in oncology. Read our white paper below that...